Background
Brian Rifkin
Is REACT (Renal Autologous Cell Therapy) the ...

This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.

Is REACT (Renal Autologous Cell Therapy) the “fifth pillar” in diabetic kidney disease?
Background
Brian Rifkin
2026 KDIGO Anemia Management Guidelines

This week, we will discuss 2026 KDIGO anemia management in patients with kidney disease

2026 KDIGO Anemia Management Guidelines
Background
Cristina Adriana Popa
To INFINITI and Beyond: SGLT2 Inhibitors in ...

This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.

To INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients
Background
Cristina Adriana Popa
POTCAST- K+ Pop and Arrhythmia Drop

This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.

POTCAST- K+ Pop and Arrhythmia Drop
Background
Brian Rifkin
A VALIANT effort to combat complement disorders ...

This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.

A VALIANT effort to combat complement disorders with pegcetacoplan

Announcing the NephJC Editorial Internship

Are you a curious, motivated nephrology fellow or early‑career faculty member with a passion for science communication? NephJC is inviting a small group of talented individuals to join our Editorial Internship Program and become part of the team that shapes how nephrology is discussed, illustrated, and shared online.

As an intern, you’ll help craft the bimonthly NephJC Journal Club, one of the most vibrant hubs for post‑publication peer review in nephrology, while developing your skills as an editor, writer, illustrator, or podcaster. We’re also planning to expand our Instagram presence this year, so creative voices with an eye for visual storytelling will have new opportunities to shine.

What this internship offers

  • Collaboration with an experienced, dynamic production team

  • Engagement with cutting‑edge nephrology research

  • Increased professional visibility within the global nephrology community

Take your passion for kidneys, curiosity, and community to the next level- join the NephJC Editorial Internship Program and help us keep the nephrology spirit alive across platforms, including a more active IG presence.

Submit your application

REACT: El Resumen Visual

REACT aterriza a #NephJC

Esta vez analizamos rilparencel, una terapia celular renal autóloga inyectada directamente en la corteza renal para enlentecer la perdida de la función renal en nefropatía diabética y ERC avanzada.

¿Estamos ante una nueva era en la nefrología?

Revisa el resumen visual por Natalia Nombera y únete a la discusión en #NephJC.

REACT: The Visual Abstract

REACT has landed to NephJC.

This time we explore rilparencel, an autologous kidney cell therapy injected directly into the renal cortex to slow kidney function decline in DKD and advanced CKD.

Is this the future of regenerative nephrology?

Take a look at the Visual Abstract Natalia Nombera and join the conversation on #NephJC.

,

2026 #NephJCKidneys vote begins

,

After an extended nomination period, it is time to vote for your favorites. Like in the previous years, you will need to be a subscriber to the newsletter to be eligible to vote. By voting you let our content creators know how much they are contributing the the FOAMed goals of NephJC.

Just one week to vote!

The link to vote will be available in the newsletter.

Subscribe to vote

Here is the final ballot:

Article of the Year

Engaged Scientist of the Year

Nathan Hellman Social Media Project of the Year

Most Valuable Player

Milagros Flores @dramiliflores.bsky.social

Brian Rifkin @brianrifkin.bsky.social

Akshaya Jaychandran @nephromommy-akshu.bsky.social

Visual Abstract of the Year

ISN-GKHA interactive map: From data to dialogue by Denisse Arellano

Akshaya Jaychandran ACHIEVE trial 

Husam Alzayer: incremental dialysis

Krithika Mohan: herb nephropathy

NephJC Social Justice Award

WHO kidney resolution and UN political declaration

World KIdney Day- Kidney health for all

KDIGO 2026 Anemia in CKD: The Visual Abstract

Anemia remains a central challenge in chronic kidney disease, influencing quality of life, cardiovascular risk, and clinical outcomes. The updated KDIGO 2026 guideline provides practical recommendations on iron management, ESAs, HIF-PHIs, and transfusion strategies, emphasizing individualized care and risk–benefit assessment.

Take a quick look at the VA by Michelle Fravel summarizing the key concepts and clinical take-home message

KDIGO 2026 Anemia en la ERC: El Resumen Visual

La anemia continúa siendo un reto clave en la enfermedad renal crónica, con impacto directo en la calidad de vida, el riesgo cardiovascular y los desenlaces clínicos. La actualización KDIGO 2026 ofrece recomendaciones prácticas sobre el manejo del hierro, el uso de AEEs, PHI-HIFs y estrategias de transfusión, con énfasis en una toma de decisiones individualizada basada en riesgo-beneficio.

Revisa el resumen visual realizado por Michelle Fravel , donde resume los mensajes clave y las principales perlas clínicas de la guía 2026.

INFINITI: The Visual Abstract

SGLT2i have reshaped cardiorenal care, but kidney transplant recipients have mostly been left out of the story. INFINITI starts to close that gap, testing the safety and physiology of dapagliflozin in stable KTR.

Do #flozins behave the same in transplanted kidneys? Check out the VA by Janany Sabescumar

INFINITI: El Resumen Visual

Los iSGLT2 han revolucionado la protección cardiorrenal, pero los trasplantados renales han quedado fuera de la historia. El ensayo INFINITI empieza a cerrar esa brecha. ¿Flozinaran igual los iSGLT2 en el riñón trasplantado? Revisa el resumen visual creado por Janany Sabescumar

NephJC on Instagram

NephJC continues to host its live journal clubs and real-time discussions on Bluesky where open dialogue, shared learning, and critical appraisal are central to what we do. For now, our scheduled chats and discussions will continue on Bluesky.

We are also expanding our presence on Instagram with a complementary goal. Instagram allows us to connect with nephrologists and the public who may not be active on X or Bluesky but who are still interested in practice-relevant research, methodology, and staying informed on ongoing NephJC activities. For many clinicians, Instagram serves as an accessible entry point rather than a space for in-depth discussion.

The NephJC editorial team recognizes that Instagram does not allow for the same type of open, back-and-forth dialogue that defines our journal clubs. We are not aiming to replicate that experience there. Instead, we see Instagram as a way to highlight important studies, share key concepts, and guide interested readers toward platforms where deeper discussion and engagement are possible.

Our commitment to thoughtful, inclusive, and rigorous discussion remains the same. Instagram is simply another way to welcome more colleagues into the NephJC community.

Follow us

POTCAST: El Resumen Visual

¿Elevar el K⁺ al rango alto-normal puede reducir las descargas del DAI y las hospitalizaciones? POTCAST desafía nuestro miedo al potasio.

Revisa el resumen visual por Jeyakumar Meyyappan y únete a la conversación en #NephJC

TenPosts: pegcetacoplan in C3GN

Check out VALIANT recap: a 26-week analysis of the phase 3 trial of pegcetacoplan in C3GN! Thread by NephJC intern Bogdan Agavriloaei.